ibn-salem ozlemmuslu commited on
Commit
dca333c
·
verified ·
1 Parent(s): d7586ed

Update README.md (#1)

Browse files

- Update README.md (12b963f9a1d16328f40e2383ec63b539ac01a6f6)


Co-authored-by: Özlem Muslu <ozlemmuslu@users.noreply.huggingface.co>

Files changed (1) hide show
  1. README.md +68 -3
README.md CHANGED
@@ -1,3 +1,68 @@
1
- ---
2
- license: cc-by-nc-nd-4.0
3
- ---
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ---
2
+ language:
3
+ - en
4
+
5
+ license: cc-by-nc-nd-4.0
6
+
7
+ tags:
8
+ - NGS
9
+ - somatic-variant-calling
10
+ ---
11
+
12
+ # Model Card for Model ID
13
+
14
+ This is a 3D DenseNet model for detection of somatic SNV candidates.
15
+
16
+ ## Model Details
17
+
18
+ ### Model Description
19
+
20
+ - **Developed by:** Özlem Muslu
21
+ - **Funded by :** European Research Council (“ERC Advanced Grant “SUMMIT” (Ugur Sahin): 789256”)
22
+ - **License:** cc-by-nc-nd-4.0
23
+
24
+ ### Model Sources
25
+
26
+ - **Repository:** https://github.com/TRON-Bioinformatics/VariantMedium
27
+
28
+ ## Uses
29
+
30
+ Using matched tumor-normal paired short read sequencing data, you can call a list of somatic point mutations.
31
+
32
+
33
+ ### Downstream Use
34
+
35
+ This model is a part of VariantMedium somatic variant caller and is integrated directly into its workflow https://github.com/TRON-Bioinformatics/VariantMedium
36
+
37
+ ### Out-of-Scope Use
38
+
39
+ The model on its own is not intended to create a final list of variant calls, it is intended a part of a pipeline (https://github.com/TRON-Bioinformatics/VariantMedium)
40
+
41
+ ## Bias, Risks, and Limitations
42
+
43
+ The model is trained on the output of cell line WES, TCGA WES, and an AML WGS, both originating from short read Illumina sequencing. It is tested for other cancer entities and mostly for solid tumors, but is not tested for non-Illumina sequencing.
44
+
45
+ ### Recommendations
46
+
47
+ We recommend using this model for Illumina-based WES and WGS (paired, short read).
48
+
49
+ ## Training Details
50
+
51
+ ### Training Data
52
+
53
+ Matched tumor-normal sequencing published under https://ega-archive.org/studies/EGAS00001007633 , https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000178.v11.p8 , and https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000159.v13.p5.
54
+
55
+ ## Evaluation
56
+
57
+ Evaluation on two independent cohorts. More information can be found on our publication linked under: https://github.com/TRON-Bioinformatics/VariantMedium
58
+
59
+ ### Testing Data, Factors & Metrics
60
+
61
+ #### Testing Data
62
+
63
+ Tested on independent data sets:
64
+ - [PCAWG-Pilot63](https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000178.v11.p8)
65
+ - [SEQC2 WES samples](ftp://ftp-trace.ncbi.nlm.nih.gov/ReferenceSamples/seqc/Somatic_Mutation_WG/)
66
+
67
+ #### Summary
68
+